54
Participants
Start Date
February 21, 2024
Primary Completion Date
December 1, 2025
Study Completion Date
December 1, 2025
Platelet Rich Plasma Joint Injection
Magellan Autologous Concentration System, ISTO Biologics
Corticosteroid Injection
5 milliliters (mL) injection of corticosteroid (1cc Kenalog, 4cc Xylocaine) Kenalog - 40 (triamcinolone acetonide injectable suspension, USP) Xylocaine - MPF (lidocaine HCl Injection, USP)
RECRUITING
Sinai Hospital of Baltimore, Baltimore
Lead Sponsor
Hip Society
UNKNOWN
LifeBridge Health
OTHER